CXCL12 and neoplasm: In another study, we reported that the paradoxical growth of tumor following Vatalanib treatment was controlled by inhibiting the mobilization of BMDCs and disrupting the CXCR4-SDF-1α interaction using whole body irradiation and AMD3100, respectively [38].